Dolby Laboratories Share Price (NYSE: DLB)

$73.81

▲

0.01

(0.01%)

Last updated on August 20, 2025 at 1:29 AM IST

$₹

Check the interactive Dolby Laboratories Stock chart to analyse performance

Dolby Laboratories stock performance

as on August 20, 2025 at 1:29 AM IST

Today's Low:$73.52
Today's High:$74.52
$73.81
0.39%
Downside
Day's Volatility :1.34%
Upside
0.95%
52 Weeks Low:$68.24
52 Weeks High:$89.66
$73.81
7.55%
Downside
52 Weeks Volatility :23.89%
Upside
17.68%

Dolby Laboratories Stock Returns

Period	Dolby Laboratories, Inc.	Sector (Technology)	Index (Russel 2000)
3 Months	-2.58%	13.5%	0.0%
6 Months	-11.47%	10.0%	0.0%
1 Year	1.84%	18.3%	0.0%
3 Years	-3.43%	79.8%	-9.6%

Dolby Laboratories, Inc. Key Stats

Check Dolby Laboratories key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$73.8
Open	$73.91
Today's High	$74.52
Today's Low	$73.52
Market Capitalization	$7.0B
Today's Volume	$371.4K
52 Week High	$89.66
52 Week Low	$68.24
Revenue TTM	$1.3B
EBITDA	$376.4M
Earnings Per Share (EPS)	$2.75
PE Ratio	26.84
Dividend Yield	1.81%
Profit Margin	19.62%
Quarterly Earnings Growth YOY	0.2%
Return On Equity TTM	10.5%

Stock Returns calculator for Dolby Laboratories Stock including INR - Dollar returns

The Dolby Laboratories stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Dolby Laboratories investment value today

Current value as on today

₹1,06,238

Returns

₹6,238

(+6.24%)

Returns from Dolby Laboratories Stock

₹2,614 (+2.61%)

Dollar Returns*

₹3,624 (+3.62%)

Indian investors sentiment towards Dolby Laboratories Stock

25%

Period: Jul 20, 2025 to Aug 19, 2025. Change in 30 Days versus previous period

Search interest for Dolby Laboratories Stock from India on INDmoney has increased by 25% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Dolby Laboratories, Inc.

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
7.88%
Morgan Stanley - Brokerage Accounts
7.44%
BlackRock Inc
6.29%
Bank of New York Mellon Corp
5.96%
State Street Corp
2.17%
Disciplined Growth Investors Inc
1.61%

Analyst Recommendation on Dolby Laboratories Stock

Rating

Trend

Buy

62%Buy

37%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Dolby Laboratories(by analysts ranked 0 to 5 stars)

Dolby Laboratories Share Price Target

What analysts predicted

Upside of 39.55%

Target:

$103.00

Current:

$73.81

Dolby Laboratories share price target is $103.00, a slight Upside of 39.55% compared to current price of $73.81 as per analysts' prediction.

Dolby Laboratories Stock Insights

Price Movement
In the last 7 days, DLB stock has moved up by 2.0%
Decreasing Revenue
Revenue is down for the last 2 quarters, 369.56M → 315.54M (in $), with an average decrease of 14.6% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 91.79M → 46.07M (in $), with an average decrease of 49.8% per quarter
DLB vs RBA (1 yr)
In the last 1 year, Rb Global Inc has given 38.8% return, outperforming this stock by 36.2%
DLB vs CTAS (3 yr)
In the last 3 years, Cintas Corporation has given 63.7% return, outperforming this stock by 69.3%
Price to Sales
ForDLB every $1 of sales, investors are willing to pay $5.3, whereas for Rb Global Inc, the investors are paying $4.8 for every $1 of sales.

Dolby Laboratories, Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$1.2B	↑ 5.95%
Net Income	$255.2M	↑ 108.72%
Net Profit Margin	20.55%	↑ 10.12%

	FY20	Y/Y Change
Revenue	$1.2B	↓ 6.43%
Net Income	$231.4M	↓ 9.32%
Net Profit Margin	19.91%	↓ 0.64%

	FY21	Y/Y Change
Revenue	$1.3B	↑ 10.28%
Net Income	$310.2M	↑ 34.09%
Net Profit Margin	24.21%	↑ 4.3%

	FY22	Y/Y Change
Revenue	$1.3B	↓ 2.14%
Net Income	$184.1M	↓ 40.66%
Net Profit Margin	14.68%	↓ 9.53%

	FY23	Y/Y Change
Revenue	$1.0B	↓ 19.51%
Net Income	$191.5M	↑ 4.01%
Net Profit Margin	18.97%	↑ 4.29%

	FY24	Y/Y Change
Revenue	$1.3B	↑ 26.21%
Net Income	$360.6M	↑ 88.35%
Net Profit Margin	28.31%	↑ 9.34%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$364.5M	↑ 15.51%
Net Income	$97.8M	↑ 46.06%
Net Profit Margin	26.84%	↑ 5.61%

	Q2 FY24	Q/Q Change
Revenue	$288.8M	↓ 20.77%
Net Income	$38.4M	↓ 60.7%
Net Profit Margin	13.31%	↓ 13.53%

	Q3 FY24	Q/Q Change
Revenue	$304.8M	↑ 5.54%
Net Income	$58.6M	↑ 52.35%
Net Profit Margin	19.22%	↑ 5.91%

	Q4 FY24	Q/Q Change
Revenue	$357.0M	↑ 17.12%
Net Income	$67.8M	↑ 15.8%
Net Profit Margin	19.0%	↓ 0.22%

	Q1 FY25	Q/Q Change
Revenue	$369.6M	↑ 3.52%
Net Income	$91.8M	↑ 35.34%
Net Profit Margin	24.84%	↑ 5.84%

	Q2 FY25	Q/Q Change
Revenue	$315.5M	↓ 14.62%
Net Income	$46.1M	↓ 49.81%
Net Profit Margin	14.6%	↓ 10.24%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$1.1B	↑ 3.55%

	FY20	Y/Y Change
Profit	$1.0B	↓ 6.06%

	FY21	Y/Y Change
Profit	$1.2B	↑ 13.39%

	FY22	Y/Y Change
Profit	$1.1B	↓ 3.37%

	FY23	Y/Y Change
Profit	$892.2M	↓ 19.8%

	FY24	Y/Y Change
Profit	$1.1B	↑ 27.02%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$325.7M	↑ 14.9%

	Q2 FY24	Q/Q Change
Profit	$253.2M	↓ 22.28%

	Q3 FY24	Q/Q Change
Profit	$270.8M	↑ 6.97%

	Q4 FY24	Q/Q Change
Profit	$316.2M	↑ 16.77%

	Q1 FY25	Q/Q Change
Profit	$333.7M	↑ 5.53%

	Q2 FY25	Q/Q Change
Profit	$271.5M	↓ 18.63%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$327.7M	↓ 6.96%
Investing Cash Flow	$-56.2M	↓ 171.86%
Financing Cash Flow	$-385.3M	↑ 188.32%

	FY20	Y/Y Change
Operating Cash Flow	$343.8M	↑ 4.94%
Investing Cash Flow	$134.4M	↓ 338.98%
Financing Cash Flow	$-207.8M	↓ 46.07%

	FY21	Y/Y Change
Operating Cash Flow	$447.8M	↑ 30.22%
Investing Cash Flow	$-44.9M	↓ 133.42%
Financing Cash Flow	$-252.5M	↑ 21.53%

	FY22	Y/Y Change
Operating Cash Flow	$318.6M	↓ 28.85%
Investing Cash Flow	$-295.9M	↑ 559.02%
Financing Cash Flow	$-610.6M	↑ 141.79%

	FY23	Y/Y Change
Operating Cash Flow	$282.1M	↓ 11.46%
Investing Cash Flow	$54.2M	↓ 118.32%
Financing Cash Flow	$-194.0M	↓ 68.22%

	FY24	Y/Y Change
Operating Cash Flow	$327.3M	↑ 16.02%
Investing Cash Flow	$-286.3M	↓ 628.16%
Financing Cash Flow	$-287.8M	↑ 48.35%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$181.4M	↑ 2057.32%
Investing Cash Flow	$-17.9M	↓ 2923.54%
Financing Cash Flow	$-44.2M	↓ 64.71%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$21.3M	↓ 88.28%
Investing Cash Flow	$-7.7M	↓ 56.67%
Financing Cash Flow	$-58.4M	↑ 32.23%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$116.2M	↑ 446.32%
Investing Cash Flow	$-261.3M	↑ 3274.33%
Financing Cash Flow	$-60.1M	↑ 2.95%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$106.8M	↓ 8.08%
Investing Cash Flow	$-8.1M	↓ 96.88%
Financing Cash Flow	$-57.6M	↓ 4.24%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$174.9M	↑ 63.79%
Investing Cash Flow	$25.9M	↓ 418.08%
Financing Cash Flow	$-64.9M	↑ 12.68%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$349.4M	↑ 99.76%
Investing Cash Flow	$11.3M	↓ 56.26%
Financing Cash Flow	$-183.2M	↑ 182.37%

Dolby Laboratories Technicals Summary

Sell

Neutral

Buy

Dolby Laboratories is currently in a neutral trading position according to technical analysis indicators.

Dolby Laboratories, Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Dolby Laboratories, Inc.	-1.74%	-11.47%	1.84%	-3.43%	6.41%
Thomson Reuters Corp.	-14.9%	0.3%	5.74%	50.75%	124.15%
Copart, Inc.	2.87%	-20.74%	-8.91%	51.81%	88.1%
Global Payments Inc.	6.38%	-18.98%	-20.54%	-33.57%	-48.67%
Cintas Corporation	-3.21%	2.92%	10.61%	99.13%	167.44%
Rb Global Inc	6.9%	10.16%	38.35%	62.79%	82.9%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Dolby Laboratories, Inc.	26.84	26.84	2.08	3.97	0.11	0.06	0.02	27.19
Thomson Reuters Corp.	48.04	48.04	15.97	3.87	0.13	0.07	0.01	27.99
Copart, Inc.	31.18	31.18	2.33	1.56	0.18	0.12	NA	9.08
Global Payments Inc.	14.71	14.71	0.66	12.17	0.07	0.03	0.01	93.18
Cintas Corporation	48.7	48.7	4.06	4.42	0.4	0.16	0.01	11.63
Rb Global Inc	56.6	56.6	2.23	3.66	0.07	0.04	0.01	29.39

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Dolby Laboratories, Inc.	Buy	$7.0B	6.41%	26.84	19.62%
Thomson Reuters Corp.	Hold	$77.9B	124.15%	48.04	22.34%
Copart, Inc.	Buy	$45.5B	88.1%	31.18	32.21%
Global Payments Inc.	Buy	$21.0B	-48.67%	14.71	14.2%
Cintas Corporation	Buy	$86.4B	167.44%	48.7	17.53%
Rb Global Inc	Buy	$21.3B	82.9%	56.6	9.46%

Dolby Laboratories Dividend announcements

Dolby Laboratories Dividends September, 2025
In the quarter ending September,2025. Dolby Laboratories has declared dividend of $0.33

About Dolby Laboratories, Inc.

Dolby Laboratories, Inc. engages in the design and manufacture of audio, imaging, accessibility, and other hardware and software solutions primarily for application in the television, broadcast, and live entertainment industries in the United States and internationally. The company develops and licenses its audio technologies, such as AAC, HE-AAC, and extended HE-AAC, a digital audio codec solution; AVC, a digital video codec used in STBs, mobile devices, cameras, and broadcast television services and other products; and Dolby Atmos and Dolby Vision include encoding technologies that artists use to create more compelling and immersive audio and video experiences. Its audio technologies also include DD+, an advanced surround sound audio codec technology; Dolby AC-4, an audio codec that uses cutting edge compression; and HEVC, a next-generation digital video codec that compresses video. In addition, the company offers Dolby Cinemas, a premium large format cinemas that deliver a Dolby branded premium cinema offering with Dolby Vision, Dolby Atmos, and a Dolby theater design; Dolby.io, a next generation SaaS product of immersive, interactive, and social experiences with real-time engagement for live events, especially sports; and digital cinema servers, cinema processors, amplifiers, loudspeakers, and audio and imaging hardware and software products for the cinema, television, broadcast, communication, and entertainment industries. Further, it provides various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. The company serves film studios, content creators, post-production facilities, and broadcasters. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.

Organization	Dolby Laboratories
Employees	2080
CEO	Mr. Kevin J. Yeaman
Industry	Manufacturing

Key Management of Dolby Laboratories, Inc.

Name	Title
Mr. Kevin J. Yeaman	President, CEO & Director
Mr. Robert J. Park	Senior VP & CFO
Mr. Andy Sherman J.D.	Executive VP, General Counsel & Corporate Secretary
Mr. John D. Couling	Senior Vice President of Entertainment
Dr. Shriram Revankar	Senior Vice President of Advanced Technology Group
Mr. Ryan Nicholson	VP, Corporate Controller & Chief Accounting Officer
Mr. Edwin Marin	Senior VP & Chief Information Officer
Mr. Peter L. Goldmacher	Vice President of Investor Relations
Mr. Todd Pendleton	Senior VP & Chief Marketing Officer
Ms. Linda Rogers	Senior VP & Chief People Officer

Important FAQs about investing in DLB Stock from India :

What is Dolby Laboratories share price today?

Dolby Laboratories share price today is $73.81 as on August 20, 2025 at 1:29 AM IST at the close of the market. Dolby Laboratories share today touched a day high of $74.52 and a low of $73.52.

What is the 52 week high and 52 week low for Dolby Laboratories share?

Dolby Laboratories share touched a 52 week high of $89.66 and a 52 week low of $68.24. Dolby Laboratories stock price today i.e. August 20, 2025 at 1:29 AM IST is closed at $73.81, lower by 17.68% versus the 52 week high.

How to invest in Dolby Laboratories Stock (DLB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Dolby Laboratories on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dolby Laboratories Shares that will get you 0.0203 shares as per Dolby Laboratories share price of $73.81 per share as on August 20, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Dolby Laboratories Stock (DLB) from India?

Indian investors can start investing in Dolby Laboratories (DLB) shares with as little as ₹86.938 or $1 (as of August 20, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹869.38 in Dolby Laboratories stock (as per the Rupee-Dollar exchange rate as on August 20, 2025). Based on Dolby Laboratories share’s latest price of $73.81 as on August 20, 2025 at 1:29 AM IST, you will get 0.1355 shares of Dolby Laboratories. Learn more about fractional shares .

What are the returns that Dolby Laboratories has given to Indian investors in the last 5 years?

Dolby Laboratories stock has given 6.41% share price returns and 16.15% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?